Novel Immunotherapy Drug Receives FDA Approval for the Treatment of Metastatic Melanoma

Friday, April 8, 2011 - 21:30 in Health & Medicine

On March 25, the US Food and Drug Administration announced that the drug ipilimumab (brand name Yervoy) was approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net